Cargando…

Pseudomonas aeruginosa isolation in patients with non-cystic fibrosis bronchiectasis: a retrospective study

OBJECTIVES: Pseudomonas aeruginosa (P. aeruginosa) occupies an important niche in the pathogenic microbiome of bronchiectasis. The objective of this study is to evaluate the clinical characteristics and prognostic value of P. aeruginosa in Chinese adult patients with bronchiectasis. METHODS: This re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hong, Ji, Xiao-Bin, Mao, Bei, Li, Cheng-Wei, Lu, Hai-Wen, Xu, Jin-Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Respiratory Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857665/ https://www.ncbi.nlm.nih.gov/pubmed/29540404 http://dx.doi.org/10.1136/bmjopen-2016-014613

Ejemplares similares

KMBARC registry: protocol for a multicentre observational cohort study on non-cystic fibrosis bronchiectasis in Korea
por: Lee, Hyun, et al.
Publicado: (2020)

Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative study
por: Palser, Sally C, et al.
Publicado: (2016)

Daily versus three-times-weekly azithromycin in Chinese patients with non-cystic fibrosis bronchiectasis: protocol for a prospective, open-label and randomised controlled trial
por: Mao, Yanxiong, et al.
Publicado: (2022)

Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006–2021: a systematic review and meta-analysis
por: Zhou, Yunchun, et al.
Publicado: (2022)

Observational study of sleep, respiratory mechanics and quality of life in patients with non-cystic fibrosis bronchiectasis: a protocol study
por: Faria Júnior, Newton Santos, et al.
Publicado: (2015)

Efficacy of N-acetylcysteine on idiopathic or postinfective non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis protocol
por: Luo, Ai, et al.
Publicado: (2022)

Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis
por: Hsieh, Meng-Heng, et al.
Publicado: (2018)

Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis and Pseudomonas aeruginosa
por: Singh, Jagdev, et al.
Publicado: (2023)

Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
por: Hilliam, Yasmin, et al.
Publicado: (2017)

Isolation of and risk factors for airway infection with Pseudomonas aeruginosa in patients with non-cystic fibrosis bronchiectasis
por: Figueiredo, Mara Rúbia, et al.
Publicado: (2021)

Stratified assessment of the role of inhaled hypertonic saline in reducing cystic fibrosis pulmonary exacerbations: a retrospective analysis
por: Dmello, Dayton, et al.
Publicado: (2011)

Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis
por: Blanco-Aparicio, Marina, et al.
Publicado: (2019)

Utility of a personalised Bronchiectasis Action Management Plan (BAMP) for children with bronchiectasis: protocol for a multicentre, double-blind parallel, superiority randomised controlled trial
por: Marchant, Julie M, et al.
Publicado: (2021)

Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis
por: Woo, Taylor E., et al.
Publicado: (2018)

Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications
por: Kwok, Wang Chun, et al.
Publicado: (2021)

A systematic review of patient-reported outcome measures (PROMs) in cystic fibrosis
por: Ratnayake, Irushi, et al.
Publicado: (2020)

Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis
por: Morton, Miranda, et al.
Publicado: (2023)

Longitudinal impact of demographic and clinical variables on health-related quality of life in cystic fibrosis
por: Abbott, Janice, et al.
Publicado: (2015)

Survey of exercise testing and training in cystic fibrosis clinics in the UK: a decade of progress
por: Tomlinson, Owen William, et al.
Publicado: (2023)

Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator–IL-6–antimicrobial–repair pathway
por: Saint-Criq, Vinciane, et al.
Publicado: (2018)

Prognostic performance of the FACED score and bronchiectasis severity index in bronchiectasis: a systematic review and meta-analysis
por: He, Min, et al.
Publicado: (2020)

Feasibility study for supporting medication adherence for adults with cystic fibrosis: mixed-methods process evaluation
por: Hind, Daniel, et al.
Publicado: (2020)

A smartphone application for reporting symptoms in adults with cystic fibrosis: protocol of a randomised controlled trial
por: Wood, Jamie, et al.
Publicado: (2018)

Protocol for establishing a core outcome set for evaluation in studies of pulmonary exacerbations in people with cystic fibrosis
por: McLeod, Charlie, et al.
Publicado: (2022)

The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis
por: Dhand, Rajiv
Publicado: (2018)

Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains
por: Varga, John J., et al.
Publicado: (2015)

Changes in Clinical Markers During A Short-Term Transfer Program of Adult Cystic Fibrosis Patients from Pediatric to Adult Care
por: Welsner, Matthias, et al.
Publicado: (2019)

Protocol for Project Fizzyo, an analytic longitudinal observational cohort study of physiotherapy for children and young people with cystic fibrosis, with interrupted time-series design
por: Raywood, Emma, et al.
Publicado: (2020)

Barriers and facilitators to physical activity among children, adolescents, and young adults with cystic fibrosis: a systematic review and thematic synthesis of qualitative research
por: Denford, Sarah, et al.
Publicado: (2020)

Altered fecal microbiome and metabolome in adult patients with non-cystic fibrosis bronchiectasis
por: Wang, Wen-Wen, et al.
Publicado: (2022)

Response to inhaled ceftazidime in patients with non‐cystic fibrosis bronchiectasis and chronic bronchial infection unrelated to Pseudomonas aeruginosa
por: Riveiro, Vanessa, et al.
Publicado: (2022)

The contribution of Pseudomonas aeruginosa infection to clinical outcomes in bronchiectasis: a prospective cohort study
por: Wang, Rongchun, et al.
Publicado: (2021)

Prognosis of acute exacerbation in idiopathic pulmonary fibrosis with pulmonary emphysema: a retrospective cohort study in Japan
por: Horio, Yukihiro, et al.
Publicado: (2022)

Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S.
por: Blanchette, Christopher M., et al.
Publicado: (2017)

Retrospective observational study of trends in hospital admissions for idiopathic pulmonary fibrosis in Spain (2004–2013) using administrative data
por: Pedraza-Serrano, Fernando, et al.
Publicado: (2017)

Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis
por: Lancaster, Lisa, et al.
Publicado: (2020)

Disinfection of Pseudomonas aeruginosa from N95 respirators with ozone: a pilot study
por: Manning, Edward P, et al.
Publicado: (2021)

Bronchiectasis and the risk of cardiovascular disease: a population-based study
por: Navaratnam, Vidya, et al.
Publicado: (2017)

Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts
por: McDonnell, M J, et al.
Publicado: (2016)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3n8al0d66m0ns3t1914b6ir7kd